Prescott General Partners LLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 75 filers reported holding HUMACYTE INC in Q2 2023. The put-call ratio across all filers is 45.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
Prescott General Partners LLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$1,664,961
+2.4%
568,2460.0%0.11%
+6.0%
Q2 2023$1,625,184
-7.4%
568,2460.0%0.10%
-28.1%
Q1 2023$1,755,880
+46.4%
568,2460.0%0.14%
+43.3%
Q4 2022$1,198,999
-35.3%
568,2460.0%0.10%
-33.1%
Q3 2022$1,852,000
+1.5%
568,2460.0%0.14%
+16.0%
Q2 2022$1,824,000
-58.7%
568,246
-9.1%
0.12%
-37.8%
Q1 2022$4,413,000
+660.9%
625,100
+681.4%
0.20%
+905.0%
Q4 2021$580,00080,0000.02%
Other shareholders
HUMACYTE INC shareholders Q2 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders